8607 related articles for article (PubMed ID: 17631784)
1. An unusual pattern of pseudoepitheliomatous hyperplasia associated with cutaneous primary melanoma: report of two cases with analysis of p53 and bcl-2 immunoreactivity.
Vucić M; Cupić H; Tomić K; Kruslin B
Acta Dermatovenerol Croat; 2007; 15(2):72-5. PubMed ID: 17631784
[TBL] [Abstract][Full Text] [Related]
2. Oral malignant melanoma associated with pseudoepitheliomatous hyperplasia. Report of a case.
Meleti M; Mooi WJ; van der Waal I
J Cutan Pathol; 2006 Apr; 33(4):331-3. PubMed ID: 16630188
[TBL] [Abstract][Full Text] [Related]
3. Melanoma associated with pseudoepitheliomatous hyperplasia: a case series and investigation into the role of epidermal growth factor receptor.
Mott RT; Rosenberg A; Livingston S; Morgan MB
J Cutan Pathol; 2002 Sep; 29(8):490-7. PubMed ID: 12207743
[TBL] [Abstract][Full Text] [Related]
4. Pseudoepitheliomatous hyperplasia formation after skin injury.
Fu X; Jiang D; Chen W; Sun Bs T; Sheng Z
Wound Repair Regen; 2007; 15(1):39-46. PubMed ID: 17244318
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation and p53 expression in pseudoepitheliomatous hyperplasia of oral paracoccidioidomycosis.
Kaminagakura E; Bonan PR; Lopes MA; Almeida OP
Mycoses; 2006 Sep; 49(5):393-6. PubMed ID: 16922791
[TBL] [Abstract][Full Text] [Related]
6. [Malignant melanoma with pseudoepitheliomatous reaction marker. A case report].
Putrino I; Baccarini P; Bracko M; Foschini MP; Collina G
Pathologica; 1998 Aug; 90(4):397-402. PubMed ID: 9793402
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
8. Pseudoepitheliomatous hyperplasia: a review.
Zayour M; Lazova R
Am J Dermatopathol; 2011 Apr; 33(2):112-22; quiz 123-6. PubMed ID: 21399447
[TBL] [Abstract][Full Text] [Related]
9. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors?
Barkan GA; Paulino AF
Ann Diagn Pathol; 2003 Apr; 7(2):73-7. PubMed ID: 12715330
[TBL] [Abstract][Full Text] [Related]
10. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
Hussein MR; Al-Badaiwy ZH; Guirguis MN
J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
[TBL] [Abstract][Full Text] [Related]
11. p53 plays a central role in UVA and UVB induced cell damage and apoptosis in melanoma cells.
Zhang H
Cancer Lett; 2006 Dec; 244(2):229-38. PubMed ID: 16504377
[TBL] [Abstract][Full Text] [Related]
12. Mucocutaneous pseudoepitheliomatous hyperplasia: a review.
El-Khoury J; Kibbi AG; Abbas O
Am J Dermatopathol; 2012 Apr; 34(2):165-75. PubMed ID: 21993336
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous malignant melanoma associated with extensive pseudoepitheliomatous hyperplasia. Report of a case and discussion of the origin of pseudoepitheliomatous hyperplasia.
Hanly AJ; Jorda M; Elgart GW
J Cutan Pathol; 2000 Mar; 27(3):153-6. PubMed ID: 10728819
[TBL] [Abstract][Full Text] [Related]
14. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.
Guerriere-Kovach PM; Hunt EL; Patterson JW; Glembocki DJ; English JC; Wick MR
Am J Clin Pathol; 2004 Jul; 122(1):70-7. PubMed ID: 15272532
[TBL] [Abstract][Full Text] [Related]
15. bcl-2 protein expression in melanocytic neoplasms of the skin.
Ramsay JA; From L; Kahn HJ
Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma.
Ross DA; Wilson GD
Br J Surg; 1997 Jun; 84(6):803-7. PubMed ID: 9189093
[TBL] [Abstract][Full Text] [Related]
17. Langerhans cells in squamous cell carcinoma vs. pseudoepitheliomatous hyperplasia of the skin.
Galan A; Ko CJ
J Cutan Pathol; 2007 Dec; 34(12):950-2. PubMed ID: 18001421
[TBL] [Abstract][Full Text] [Related]
18. bcl-2 expression in the spectrum of preinvasive breast lesions.
Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
[TBL] [Abstract][Full Text] [Related]
19. [Expression of P53 protein in cutaneous melanoma].
Casazza S; Gambini C; Tunesi G; Rovida S; Caruso F; Pastorino A; Canepa M
Pathologica; 1993; 85(1097):335-42. PubMed ID: 8233650
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
